Androgel 17139-0525-30
Generic: Testosterone
- Manufacturer
- Ascend Therapeutics U.s., Llc
- Dosage Form
- Gel
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 17, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA021015
Active Ingredients
| Ingredient | Strength |
|---|---|
| Testosterone | 10 mg/g |
Drug Class
Androgen [EPC]Androgen Receptor Agonists [MoA]Androgen [EPC]
Selected Package
17139-0525-30Selected30 PACKET in 1 CARTON (17139-525-30) / 2.5 g in 1 PACKET